Navigation Links
Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine

Antigenics Pharmaceuticals is to start its Phase III cancer vaccine trial against Melanoma which is a type of skin cancer. Oncophage is the new skin cancer vaccine developed by Antigenics.// The vaccine trial of Oncophage which was conducted in 322 patients failed to meet the required statistically significance results compared to prolongation in survival and the vaccine was not shown to have any better results compared to other cancer treatments.

But, earlier studies with Oncophage showed a group of patients with the least-advanced severity of melanoma in the trial lived 20.9 months on Oncophage compared to 12.8 months for those patients taking standard drugs, the company said. The difference had not yet reached statistical significance and the trial is continuing.

Antigenics is to start a Phase III study next year to test its vaccine on a more responsive group, patients with Stage IV M1a patients. Though, the trial is to cost the company more than $12 million the scientists of the company are confident over the results.

Needham & Co. analyst Mark Monane in a research note called the data "encouraging" but only "hypothesis-generating rather than hypothesis-confirming, that we believe that any intensive reading into the data at this stage may be premature."
'"/>




Page: 1

Related medicine news :

1. FDA approves Watson Pharmaceuticals Oxytrol patch
2. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
3. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
4. Top Pharmaceuticals Influence Doctors Prescriptions
5. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
6. Personalized Medicine and Innovative Pharmaceuticals
7. Pravastatin Launched by Watson Pharmaceuticals
8. Tata Industries picks up stake in Indigene Pharmaceuticals
9. Pharmaceuticals May not Pose Major Aquatic Environmental Risks
10. OPPI Opposes Draft National Pharmaceuticals Policy
11. Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... ... ... While it is commonly understood that good nutrition promotes general health, consumers are becoming ... in some cases, reverse certain medical conditions, according to health and wellness research by ... to manage a health or medical condition by making healthy food and beverage choices. ...
(Date:8/12/2019)... ... August 12, 2019 , ... Cryotherapy has recently been the ... the Oakland Raiders. However, the cause of Brown’s injury was not due to cryotherapy, ... cryotherapy session. Numerous NFL teams, such as the Dallas Cowboys, the Washington Redskins, the ...
(Date:8/12/2019)... ... August 12, 2019 , ... Injured veterans from ... received through the 4th annual Lockton Warfighter Sports Charity Challenge being held on ... , Participating in the event again this year will be fifty wounded warfighters ...
(Date:8/9/2019)... ... August 09, 2019 , ... Advanced Clinical, a clinical ... into Europe’s third largest pharmaceutical market with the recent opening of a new, ... now completes the organization’s thorough coverage of Western Europe. Access to an extensive ...
(Date:8/9/2019)... (PRWEB) , ... August 09, 2019 , ... ... tools, has recently launched the EasyEyes v1.0 brightness adjusting software which helps in ... society, with users staring at the screens for several hours per day. This ...
Breaking Medicine News(10 mins):
(Date:8/15/2019)... ... 15, 2019 , ... Men’s Health Memorial will celebrate the grand opening of ... how to regain their strength and vitality. , “While many men may notice ... something about it is not always easy,” said Robert A. Ochoa, MD, Medical Director ...
(Date:8/15/2019)... ... August 15, 2019 , ... Inc. magazine ... most prestigious ranking of the nation’s fastest-growing private companies. The list represents a ... segment—its independent small businesses. Microsoft, Dell, Domino’s Pizza, Pandora, Timberland, LinkedIn, Yelp, Zillow, ...
(Date:8/14/2019)... ... 14, 2019 , ... Bach Pharma, Inc., a company based ... platform GVT (Monosodium Luminol), created to treat and cure multiple neurodegenerative diseases including ... multiple animal studies have proven that GVT has the potential to help millions ...
Breaking Medicine Technology: